Scarica l'app Stockscreener
259.69
0.36%
-0.909
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$260.60
Aprire:
$262.03
Volume 24 ore:
250.48K
Relative Volume:
0.17
Capitalizzazione di mercato:
$73.33B
Reddito:
$16.08B
Utile/perdita netta:
$2.09B
Rapporto P/E:
35.66
EPS:
7.2815
Flusso di cassa netto:
$1.90B
1 W Prestazione:
-3.65%
1M Prestazione:
-3.67%
6M Prestazione:
+1.27%
1 anno Prestazione:
+2.78%
Intervallo 1D:
$259.02
$263.10
Intervallo di 1 settimana:
$254.53
$269.96
Portata 52W:
$249.04
$309.27
Ecolab Inc Stock (ECL) Company Profile
Nome
Ecolab Inc
Settore
Industria
Telefono
18002326522
Indirizzo
1 ECOLAB PLACE, SAINT PAUL, MN
Compare ECL vs LIN, SHW, APD, SQM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ECL
Ecolab Inc
|
259.64 | 75.40B | 16.08B | 2.09B | 1.90B | 7.2815 |
LIN
Linde plc Ordinary Share
|
513.04 | 236.47B | 33.99B | 7.06B | 5.09B | 14.60 |
SHW
Sherwin Williams Co
|
318.33 | 80.21B | 23.94B | 2.60B | 2.91B | 10.42 |
APD
Air Products Chemicals Inc
|
301.22 | 67.54B | 12.21B | -304.80M | -2.81B | -1.5006 |
SQM
Sociedad Quimica Y Minera De Chile Sa Adr
|
92.14 | 25.54B | 4.58B | 641.12M | 437.00M | 2.0592 |
Ecolab Inc Stock (ECL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-20 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2026-03-24 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2026-03-16 | Aggiornamento | Berenberg | Hold → Buy |
| 2026-01-23 | Downgrade | Erste Group | Buy → Hold |
| 2025-11-03 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-10-14 | Iniziato | Erste Group | Buy |
| 2025-08-26 | Ripresa | Raymond James | Mkt Perform |
| 2025-07-30 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-04-21 | Aggiornamento | Seaport Research Partners | Neutral → Buy |
| 2025-04-16 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-03-24 | Downgrade | Redburn Atlantic | Buy → Neutral |
| 2025-01-28 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-17 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2024-11-04 | Downgrade | UBS | Buy → Neutral |
| 2024-10-18 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-08-13 | Iniziato | Wells Fargo | Overweight |
| 2024-07-31 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-07-31 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-07-08 | Aggiornamento | Stifel | Hold → Buy |
| 2024-04-12 | Aggiornamento | Mizuho | Neutral → Buy |
| 2024-04-03 | Iniziato | Piper Sandler | Overweight |
| 2024-03-01 | Iniziato | Wolfe Research | Peer Perform |
| 2024-02-28 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-02-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-01-16 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-01-08 | Downgrade | Seaport Research Partners | Buy → Neutral |
| 2023-11-30 | Iniziato | Raymond James | Outperform |
| 2023-09-01 | Iniziato | Berenberg | Hold |
| 2023-07-05 | Downgrade | Northcoast | Buy → Neutral |
| 2023-06-14 | Iniziato | Citigroup | Neutral |
| 2023-04-17 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-02-15 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-12-02 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-11-02 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-10-13 | Aggiornamento | Seaport Research Partners | Neutral → Buy |
| 2022-09-06 | Aggiornamento | Northcoast | Neutral → Buy |
| 2022-07-15 | Iniziato | Northcoast | Neutral |
| 2022-07-13 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-07-13 | Iniziato | Wells Fargo | Overweight |
| 2022-06-03 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2022-06-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-05-20 | Ripresa | Credit Suisse | Neutral |
| 2022-04-27 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-04-05 | Iniziato | Atlantic Equities | Overweight |
| 2022-03-22 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-03-17 | Aggiornamento | Edward Jones | Hold → Buy |
| 2022-02-16 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2022-02-15 | Downgrade | Boenning & Scattergood | Outperform → Neutral |
| 2022-01-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-12-03 | Ripresa | Evercore ISI | In-line |
| 2021-10-27 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-10-13 | Iniziato | Mizuho | Neutral |
| 2021-09-27 | Iniziato | Vertical Research | Hold |
| 2021-09-03 | Ripresa | RBC Capital Mkts | Outperform |
| 2021-08-16 | Downgrade | Evercore ISI | Outperform → In-line |
| 2021-04-28 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2021-03-30 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2021-03-29 | Ripresa | Credit Suisse | Neutral |
| 2021-03-15 | Ripresa | Credit Suisse | Neutral |
| 2021-01-15 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2020-09-22 | Iniziato | Evercore ISI | Outperform |
| 2020-07-28 | Aggiornamento | Boenning & Scattergood | Neutral → Outperform |
| 2020-07-08 | Ripresa | BofA Securities | Neutral |
| 2020-06-03 | Downgrade | Gabelli & Co | Buy → Hold |
| 2020-03-17 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-02-07 | Downgrade | Boenning & Scattergood | Outperform → Neutral |
| 2019-05-01 | Reiterato | BofA/Merrill | Buy |
| 2019-04-18 | Downgrade | UBS | Buy → Neutral |
| 2019-02-20 | Downgrade | JP Morgan | Overweight → Neutral |
| 2018-10-31 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-10-23 | Ripresa | BofA/Merrill | Buy |
| 2018-06-22 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-05-02 | Downgrade | JP Morgan | Overweight → Neutral |
| 2018-01-24 | Reiterato | Stifel | Hold |
| 2018-01-05 | Downgrade | Citigroup | Buy → Neutral |
| 2017-11-07 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-09-12 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-08-15 | Iniziato | Morgan Stanley | Equal-Weight |
| 2017-08-02 | Reiterato | UBS | Buy |
| 2017-05-26 | Aggiornamento | JP Morgan | Neutral → Overweight |
Mostra tutto
Ecolab Inc Borsa (ECL) Ultime notizie
How Investors May Respond To Ecolab (ECL) Boosting 2026 Outlook And Expanding Digital Water Solutions - simplywall.st
Bank of America Cuts Ecolab (ECL) Price Target, Maintains Buy on Long-Term Outlook - Insider Monkey
Ecolab Inc. stock outperforms competitors on strong trading day - MarketWatch
Ecolab slips after in-line Q1; Q2 earnings guidance mostly below consensus - MSN
11 AI Data Center Cooling Stocks to Own After the Ecolab-CoolIT Deal - MarketWise
Ecolab Life Sciences expands global bioprocessing capabilities with new centre in Korea - BioSpectrum Asia
Ecolab Life Sciences Opens Bioprocessing Applications Lab in Korea to Support Downstream Process Development Across Asia - CHEManager
Global Cold-Chain Friendly Post-Harvest Sanitizing Mist Market Outlook 2036: Growth Trends Led by AgroFresh, Ecolab, and Evonik - Morningstar
BMO Capital Reaffirms Their Buy Rating on Ecolab (ECL) - The Globe and Mail
Bioprocessing Applications Laboratory Opened in Korea by Ecolab Life Sciences - Genetic Engineering and Biotechnology News
Ecolab Inc. Stock (US2824031014): Dividend Hike Signals Steady Shareholder Returns - AD HOC NEWS
Ecolab Life Sciences opens bioprocessing applications lab in Korea to support downstream process development across Asia - Manufacturing Chemist
Ecolab Inc (ECL) Shares Fall 3.9% -- GF Value Says Still Overval - GuruFocus
Vanguard Capital Management owns 19.0M Ecolab shares (ECL) — 6.72% - Stock Titan
Ecolab to Webcast Annual Meeting on May 7, 2026 - Business Wire
Ecolab Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
A Quick Look at Today's Ratings for Ecolab(ECL.US), With a Forecast Between $290 to $345 - Moomoo
Ecolab Opens Bioprocessing Applications Lab in Korea, Its First Bioprocessing Facility in Asia - Contract Pharma
Ecolab Reports Strong Earnings Growth - Chemical Industry Digest
Citigroup Adjusts Price Target on Ecolab to $325 From $330, Maintains Buy Rating - marketscreener.com
Baird Adjusts Price Target on Ecolab to $290 From $296, Maintains Outperform Rating - marketscreener.com
Ecolab Inc. (NYSE:ECL) Q1 2026 Earnings Call Transcript - Insider Monkey
Ecolab Life Sciences Expands Global Bioprocessing Capabilities With New Advanced Development and Applications Center in Korea - Business Wire
Research Alert: CFRA Maintains Buy Opinion On Shares Of Ecolab Inc. - Moomoo
Corrosion Inhibitors Market: Asia Leads Growth as Ecolab, BASF, Nouryon Drive 2036 Outlook - openPR.com
Ecolab Inc (ECL) Q1 2026 Earnings Call Highlights: Strong Growth Amidst Challenges - GuruFocus
Here's why you should retain Ecolab stock in your portfolio now - MSN
Ecolab Earnings Call Highlights Growth, Margin Momentum - TipRanks
Ecolab Poised for Long-Term Growth as Strong Customer Switching Costs Drive Pricing Power - Morningstar
Ecolab (ECL) Margin Slippage Puts Bullish Efficiency Narrative To The Test - simplywall.st
US278865BF65 Bond Risk Analysis - TradingView
Ecolab anticipates 12% to 15% 2026 EPS growth while building a $1.5B global hi-tech platform and absorbing $0.20 quarterly CoolIT dilution - MSN
Ecolab Inc. (ECL) Q1 2026 Earnings Call Transcript Summary - 富途牛牛
Ecolab Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Ecolab Q1 Earnings Call Highlights - Yahoo Finance
Ecolab Q1 2026: Revenue Hits $4.07B, Up 10% Year-Over-Year - AlphaStreet
Ecolab Q1 2026 slides: double-digit EPS growth, margin expansion By Investing.com - Investing.com Canada
Transcript : Ecolab Inc., Q1 2026 Earnings Call, Apr 28, 2026 - marketscreener.com
Ecolab Q1 2026 slides: double-digit EPS growth, margin expansion - Investing.com
Ecolab (ECL) Q1 2026 Earnings Call Transcript - The Motley Fool
Earnings call transcript: Ecolab Q1 2026 meets EPS forecast, slight revenue beat - Investing.com
Full Transcript: Ecolab Q1 2026 Earnings Call - Benzinga
Ecolab Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:ECL) 2026-04-28 - Seeking Alpha
Stifel reiterates Ecolab stock rating on mixed quarterly results By Investing.com - Investing.com Canada
Ecolab forecasts second-quarter profit below estimates as Iran war pushes up costs - marketscreener.com
Stifel reiterates Ecolab stock rating on mixed quarterly results - Investing.com
Ecolab’s Profit Outlook Fell Short As Oil And Freight Costs Rose - Finimize
Ecolab expect long-term organic sales growth 5%-7% - marketscreener.com
Ecolab (ECL) Reports Q1 Earnings, Issues Mixed Guidance - GuruFocus
Ecolab Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Weaving industry relationships: Richard Haworth & Ecolab - Laundry & Cleaning Today
Ecolab Inc Azioni (ECL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.92%
0.46%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):